ReviewIndian journal of ophthalmology
Thyroid associated orbitopathy.
Review in Indian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Mammalian PI-Phospholipase C Isozymes: Structural and Functional Insights and Roles in Health and Disease.Medicina (Kaunas, Lithuania) · 2025Review
- The role of mycophenolate mofetil in the therapy of thyroid eye disease.Therapeutic advances in endocrinology and metabolism · 2025Review
- Specific static and dynamic functional network connectivity changes in thyroid-associated ophthalmopathy and it predictive values using machine learning.Frontiers in neuroscience · 2024Article
- The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy.BMC ophthalmology · 2023Article
- Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.Clinical endocrinology · 2022Observational
- Alterations in Spontaneous Neuronal Activity and Microvascular Density of the Optic Nerve Head in Active Thyroid-Associated Ophthalmopathy.Frontiers in endocrinology · 2022Article
- miR-199a Downregulation as a Driver of the NOX4/HIF-1α/VEGF-A Pathway in Thyroid and Orbital Adipose Tissues from Graves' Patients.International journal of molecular sciences · 2021Article
- Ophthalmic Ultrasonography in Sub-Saharan Africa-A Kinshasa Experience.Diagnostics (Basel, Switzerland) · 2021Article
- IgG4 as a Biomarker in Graves' Orbitopathy.Mediators of inflammation · 2021Review
- Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography.BMC ophthalmology · 2020Article
- Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent.Indian journal of ophthalmology · 2020Article
- Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking.BMC complementary medicine and therapies · 2020Article
- Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.Disease markers · 2018Review
- Biomarker identification of thyroid associated ophthalmopathy using microarray data.International journal of ophthalmology · 2018Article
- [Orbit : Part 2: Diseases of the globe and retrobulbar space].Der Radiologe · 2017Review
- Risk Factors Associated with the Activity and Severity of Graves' Ophthalmopathy among Patients at the University of the Philippines Manila-Philippine General Hospital.Journal of the ASEAN Federation of Endocrine Societies · 2017Article
- Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy.Neuroradiology · 2016Article
- Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.PloS one · 2016Article
- The relationship between Graves' ophthalmopathy and dry eye syndrome.Clinical ophthalmology (Auckland, N.Z.) · 2015Review
- Presence of thyroid-associated ophthalmopathy in Hashimoto's thyroiditis.International journal of ophthalmology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid associated orbitopathy, also known as Graves' orbitopathy, is typically a self-limiting autoimmune process associated with dysthyroid states. The clinical presentation may vary from very mild disease to severe irreversible sight-threatening complications. Despite ongoing basic science and clinical research, the pathogenesis and highly effective therapeutic strategies remain elusive. The present article reviews the pathophysiology, clinical presentation, and management of this common, yet poorly understood disease, which remains a challenge to the ophthalmologist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.